Rasna Therapeutics (RASP) Financial Statements

3 Followers

Rasna Therapeutics Financial Overview

Rasna Therapeutics's market cap is currently $385.91K. The company's EPS TTM is $-0.0005; its P/E ratio is -0.06; Rasna Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ -314.00	$ -1.64K	-
Operating Income	$ -4.24M	$ 141.09K	$ -248.00K	$ -5.43M	$ -915.17K
EBITDA	$ -380.00K	$ 254.72K	$ -247.00K	$ -555.00K	$ -912.93K
Net Income	$ -4.44M	$ -687.00K	$ -876.00K	$ -5.35M	$ -936.38K
Balance Sheet
Cash & Short-Term Investments	$ 74.99K	$ 39.36K	$ 10.85K	$ 14.24K	$ 50.07K
Total Assets	$ 95.66K	$ 85.28K	$ 44.58K	$ 32.94K	$ 4.95M
Total Debt	$ 210.97K	$ 219.69K	$ 592.01K	$ 521.84K	$ 264.91K
Net Debt	$ 135.99K	$ 180.32K	$ 581.16K	$ 507.60K	$ 214.84K
Total Liabilities	$ 2.05M	$ 1.77M	$ 2.71M	$ 2.71M	$ 2.41M
Stockholders' Equity	$ -1.96M	$ -1.69M	$ -2.66M	$ -2.67M	$ 2.54M
Cash Flow
Free Cash Flow	$ -8.52K	$ -312.66K	$ -293.39K	$ -251.33K	$ -92.63K
Operating Cash Flow	$ -8.52K	$ -312.66K	$ -293.39K	$ -251.33K	$ -92.63K
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 44.14K	$ 341.18K	$ 290.00K	$ 215.50K	$ 100.00K

Currency in USD

Rasna Therapeutics Earnings and Revenue History

Income Statement >

Rasna Therapeutics Debt to Assets

Balance Sheet >

Rasna Therapeutics Cash Flow

Cash Flow >

Rasna Therapeutics Forecast EPS vs Actual EPS

Earnings >